Search Results - "Madsen, Martin R."
-
1
A liver secretome gene signature-based approach for determining circulating biomarkers of NAFLD severity
Published in PloS one (19-10-2022)“…Non-invasive biomarkers of non-alcoholic fatty liver disease (NAFLD) supporting diagnosis and monitoring disease progression are urgently needed. The present…”
Get full text
Journal Article -
2
Identification and Metabolic Profiling of a Novel Human Gut-derived LEAP2 Fragment
Published in The journal of clinical endocrinology and metabolism (01-02-2021)“…Abstract Context The mechanisms underlying Roux-en-Y gastric bypass (RYGB) surgery-induced weight loss and the immediate postoperative beneficial metabolic…”
Get full text
Journal Article -
3
Osteogenesis depends on commissioning of a network of stem cell transcription factors that act as repressors of adipogenesis
Published in Nature genetics (01-04-2019)“…Mesenchymal (stromal) stem cells (MSCs) constitute populations of mesodermal multipotent cells involved in tissue regeneration and homeostasis in many…”
Get full text
Journal Article -
4
A3907, a systemic ASBT inhibitor, improves cholestasis in mice by multiorgan activity and shows translational relevance to humans
Published in Hepatology (Baltimore, Md.) (01-09-2023)“…Cholestasis is characterized by intrahepatic accumulation of bile constituents, including bile acids (BAs), which promote liver damage. The apical…”
Get full text
Journal Article -
5
A liver secretome gene signature-based approach for determining circulating biomarkers of NAFLD severity
Published in PloS one (19-10-2022)“…Non-invasive biomarkers of non-alcoholic fatty liver disease (NAFLD) supporting diagnosis and monitoring disease progression are urgently needed. The present…”
Get full text
Journal Article -
6
483-P: Key Biochemical and Histopathological Markers of Diabetic Nephropathy Correlate with Hypertension in the Renin-AAV Uninephrectomized db/db Mouse Model
Published in Diabetes (New York, N.Y.) (01-06-2020)“…Introduction: Diabetic nephropathy (DN) is a long-term complication that occurs in ∼40% of diabetes patients and is a leading cause of end-stage renal disease…”
Get full text
Journal Article -
7
Author Correction: Osteogenesis depends on commissioning of a network of stem cell transcription factors that act as repressors of adipogenesis
Published in Nature genetics (01-04-2019)“…In the version of this article initially published, in the graph keys in Fig. 1i, the colors indicating ‘Ob’ and ‘Ad’ were red and blue, respectively, but…”
Get full text
Journal Article -
8
Glucocorticoid receptor promotes osteoblast and adipocyte differentiation by recruiting and being recruited to lineage selective enhancers
Published in Bone Reports (01-10-2020)Get full text
Journal Article -
9
1598-P: Transcriptional Profiling of the Intestinal Tract in Type 2 Diabetes-Unraveling Pathophysiological Pathways for Therapeutic Insights
Published in Diabetes (New York, N.Y.) (01-06-2024)“…Introduction and Objective: Investigating the intestinal gene expression in type 2 Diabetes (T2D) may reveal novel insights into its pathophysiology. We…”
Get full text
Journal Article -
10
-
11
Nephroprotective Effects of Semaglutide in a Mouse Model of Hypertension-Accelerated Diabetic Kidney Disease: SA-PO222
Published in Journal of the American Society of Nephrology (01-11-2022)Get full text
Journal Article -
12
Comparative Transcriptomics of Human and Mouse Diabetic Kidney Disease: TH-PO223
Published in Journal of the American Society of Nephrology (01-11-2022)Get full text
Journal Article -
13
Improvement of NASH and liver fibrosis through modulation of the gut-liver axis by a novel intestinal FXR agonist
Published in Biomedicine & pharmacotherapy (01-04-2024)“…Farnesoid X receptor (FXR) plays a pivotal role in the regulation of bile acid homeostasis and is involved in the pathogenesis of nonalcoholic steatohepatitis…”
Get full text
Journal Article